Actual Medicinal Product (AMP) Prochlorperazine 5mg tablets (Mawdsley-Brooks & Company Ltd)
This product can't be added to an MCA list.
Stability Information
(Some stability information inherited from generic)
- Stability
-
Lack of data and/or stability concerns exist. MCA use may be acceptable but is likely to be off-label and require mitigation measures. Keep medicines in MCAs for the shortest time necessary. Generally, up to 5 weeks maximum unless otherwise specified, or up to 8 weeks if the MCA is airtight (sealed). Consider the risk of potency loss or dose variability and monitor for changes in efficacy or adverse effects after MCA initiation.
- Notes
-
Light sensitive medicine. Store in light resistant container. Manufacturer recommends storing in original container.
Stability study supports 8 weeks in MCA provided product is protected from light. Grey discolouration can occur when exposed to light. - Provenance
-
This recommendation is based on the products Stemetil 5 mg tablets (Atnahs Pharma UK Ltd) and prochlorperazine 5mg tablets (Bristol Laboratories Limited).
- Generic
- Prochlorperazine
- Formulation
- Prochlorperazine 5mg tablets
-
Prochlorperazine
-
Prochlorperazine 5mg tablets
-
Prochlorperazine 5mg tablets (Mawdsley-Brooks & Company Ltd)
-
-
Prochlorperazine 3mg buccal tablets
Prochlorperazine 25mg tablets